tadalafil has been researched along with Left Ventricular Dysfunction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barberà, JA; Blair, C; Frost, AE; Galiè, N; Ghofrani, HA; Hoeper, MM; Langley, J; McLaughlin, VV; Oudiz, RJ; Peacock, AJ; Rosenkranz, S; Rubin, LJ; Simonneau, G; Vachiery, JL | 1 |
| Guo, H; Hong, B; Jin, Z; Li, L; Zhang, J; Zhang, S; Zhi, H | 1 |
| Barbaro, NR; Calhoun, D; Coelho, OR; de Faria, AP; Ferreira-Melo, SE; Fontana, V; Matos-Souza, JR; Modolo, R; Moreno, H; Santos, RC; Yugar-Toledo, JC | 1 |
| Chau, VQ; Hoke, NN; Kukreja, RC; Salloum, FN | 1 |
| Faria, AP; Modolo, R; Moreno, BV; Moreno, H | 1 |
| Das, A; Durrant, D; Filippone, S; Kukreja, RC; Nagiub, M | 1 |
| Bernheim, AM; Brunner-La Rocca, HP; Debrunner, J; Dorschner, L; Fischler, M; Kiencke, S; Maggiorini, M; Mairbäurl, H | 1 |
1 review(s) available for tadalafil and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Effects of PDE type 5 inhibitors on left ventricular diastolic dysfunction in resistant hypertension.
Topics: Carbolines; Diastole; Drug Resistance; Heart Failure, Diastolic; Humans; Hypertension; Medical Illustration; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Tadalafil; Treatment Outcome; Ventricular Dysfunction, Left | 2015 |
3 trial(s) available for tadalafil and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.
Topics: Adult; Aged; Antihypertensive Agents; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phenylpropionates; Pulmonary Arterial Hypertension; Pyridazines; Risk Factors; Tadalafil; Vasodilator Agents; Ventricular Dysfunction, Left | 2019 |
Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension.
Topics: Aged; Blood Pressure; Carbolines; Cross-Over Studies; Cyclic GMP; Diastole; Drug Resistance; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Natriuretic Peptide, Brain; Nitrites; Phosphodiesterase 5 Inhibitors; Single-Blind Method; Tadalafil; Ventricular Dysfunction, Left; Ventricular Function, Left | 2014 |
Acute changes in pulmonary artery pressures due to exercise and exposure to high altitude do not cause left ventricular diastolic dysfunction.
Topics: Adult; Altitude; Blood Flow Velocity; Carbolines; Dexamethasone; Diastole; Echocardiography, Doppler; Exercise; Exercise Test; Female; Follow-Up Studies; Glucocorticoids; Humans; Hypertension, Pulmonary; Male; Mountaineering; Myocardial Contraction; Phosphodiesterase Inhibitors; Prognosis; Pulmonary Edema; Pulmonary Wedge Pressure; Reference Values; Rest; Tadalafil; Ventricular Dysfunction, Left | 2007 |
3 other study(ies) available for tadalafil and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy.
Topics: Animals; Antibiotics, Antineoplastic; Atrophy; Carbolines; Cardiomyopathies; Cardiotonic Agents; Cyclic GMP; Disease Models, Animal; Doxorubicin; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phosphodiesterase 5 Inhibitors; Signal Transduction; Tadalafil; Ventricular Dysfunction, Left | 2013 |
Tadalafil prevents acute heart failure with reduced ejection fraction in mice.
Topics: Animals; Apoptosis; Carbolines; Cardiomegaly; Cardiomyopathies; Coronary Vessels; Heart Failure; Male; Mice; Mice, Inbred ICR; Myocardial Infarction; Phosphodiesterase Inhibitors; Pulmonary Edema; Tadalafil; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Long-acting PDE5 inhibitor tadalafil prevents early doxorubicin-induced left ventricle diastolic dysfunction in juvenile mice: potential role of cytoskeletal proteins.
Topics: Age Factors; Animals; Blotting, Western; Cardiotonic Agents; Cardiotoxicity; Cytoskeletal Proteins; Desmin; Disease Models, Animal; Doxorubicin; Echocardiography, Doppler; Mice, Inbred C57BL; Myocardium; Myosin Heavy Chains; Phosphodiesterase 5 Inhibitors; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Tadalafil; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |